These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 23207870)
1. Imaging glioma initiation in vivo through a polished and reinforced thin-skull cranial window. Zhang L; Lapierre A; Roy B; Lim M; Zhu J; Wang W; Sampson SB; Yun K; Lyons B; Li Y; Lin DT J Vis Exp; 2012 Nov; (69):. PubMed ID: 23207870 [TBL] [Abstract][Full Text] [Related]
2. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting. Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway. Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced galectin-8 maintains stemness in glioma stem cells via autophagy regulation. Liu D; Zhu H; Cheng L; Li R; Ma X; Wang J; Wang J; Zhang S; Li Y; Shu K; Yu X; Li C Neuro Oncol; 2024 May; 26(5):872-888. PubMed ID: 38158714 [TBL] [Abstract][Full Text] [Related]
5. The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment. Filatova A; Acker T; Garvalov BK Biochim Biophys Acta; 2013 Feb; 1830(2):2496-508. PubMed ID: 23079585 [TBL] [Abstract][Full Text] [Related]
6. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells. Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461 [TBL] [Abstract][Full Text] [Related]
7. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cheng L; Huang Z; Zhou W; Wu Q; Donnola S; Liu JK; Fang X; Sloan AE; Mao Y; Lathia JD; Min W; McLendon RE; Rich JN; Bao S Cell; 2013 Mar; 153(1):139-52. PubMed ID: 23540695 [TBL] [Abstract][Full Text] [Related]
8. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro. Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013 [TBL] [Abstract][Full Text] [Related]
9. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells. Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970 [TBL] [Abstract][Full Text] [Related]
10. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells. Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045 [TBL] [Abstract][Full Text] [Related]
11. The dystroglycan receptor maintains glioma stem cells in the vascular niche. Day BW; Lathia JD; Bruce ZC; D'Souza RCJ; Baumgartner U; Ensbey KS; Lim YC; Stringer BW; Akgül S; Offenhäuser C; Li Y; Jamieson PR; Smith FM; Jurd CLR; Robertson T; Inglis PL; Lwin Z; Jeffree RL; Johns TG; Bhat KPL; Rich JN; Campbell KP; Boyd AW Acta Neuropathol; 2019 Dec; 138(6):1033-1052. PubMed ID: 31463571 [TBL] [Abstract][Full Text] [Related]
12. From single-cell to spatial transcriptomics: decoding the glioma stem cell niche and its clinical implications. Cao L; Lu X; Wang X; Wu H; Miao X Front Immunol; 2024; 15():1475235. PubMed ID: 39355251 [TBL] [Abstract][Full Text] [Related]
13. Tumor vasculature and glioma stem cells: Contributions to glioma progression. Jhaveri N; Chen TC; Hofman FM Cancer Lett; 2016 Oct; 380(2):545-551. PubMed ID: 25527451 [TBL] [Abstract][Full Text] [Related]
15. Investigating the Interactions of Glioma Stem Cells in the Perivascular Niche at Single-Cell Resolution using a Microfluidic Tumor Microenvironment Model. Adjei-Sowah EA; O'Connor SA; Veldhuizen J; Lo Cascio C; Plaisier C; Mehta S; Nikkhah M Adv Sci (Weinh); 2022 Jul; 9(21):e2201436. PubMed ID: 35619544 [TBL] [Abstract][Full Text] [Related]
16. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis. Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407 [TBL] [Abstract][Full Text] [Related]
17. NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn. Guo S; Ran H; Xiao D; Huang H; Mi L; Wang X; Chen L; Li D; Zhang S; Han Q; Zhou T; Li A; Man J Cancer Lett; 2019 Jul; 454():98-107. PubMed ID: 30978441 [TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related]
19. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540 [TBL] [Abstract][Full Text] [Related]